Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jivianne Lee

Plastic Surgery within the Head & Neck Santa Monica, CA Medical Doctor

NPI 1184772972 CMS profile 368597

1131 Wilshire Blvd Ste 302, Ste 302, Santa Monica, CA 90401

Open in the dashboard

General payments

$324,365

341 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$174,254 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Jivianne Lee of Santa Monica, CA is reported in the CMS Open Payments database as having received $324,365 across 341 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $174,254 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Plastic Surgery within the Head & Neck profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $76,066 84
2024 General $42,095 47
2023 General $46,090 23
2022 General $39,243 31
2021 General $48,759 51
2020 General $30,014 46
2019 General $42,098 59

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jivianne Lee
  • Plastic Surgery within the Head & Neck median
  • Middle half of Plastic Surgery within the Head & Neck
  • National median

In program year 2025, general payments to Jivianne Lee were reported at $76,066. Among 399 Plastic Surgery within the Head & Neck profiles paid that year, the median was $237 and the middle half received between $103 and $520.

Show as a table
Year Jivianne Lee Plastic Surgery within the Head & Neck median Middle half National median
2019 $42,098 $200 $82–$550 $163
2020 $30,014 $120 $46–$330 $114
2021 $48,759 $166 $60–$382 $132
2022 $39,243 $208 $83–$530 $149
2023 $46,090 $202 $77–$538 $160
2024 $42,095 $260 $99–$645 $164
2025 $76,066 $237 $103–$520 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $72,569 83 payments
  2. Stryker Corporation $64,549 65 payments
  3. Aerin Medical Inc. $41,361 45 payments
  4. GlaxoSmithKline, LLC. $30,039 22 payments
  5. Genzyme Corporation $28,402 6 payments
  6. Intersect ENT, Inc. $24,184 25 payments
  7. Olympus Corporation of the Americas $17,156 26 payments
  8. Regeneron Healthcare Solutions, Inc. $17,073 13 payments
  9. Sanofi-Aventis U.S. LLC $15,954 5 payments
  10. Smith+Nephew, Inc. $4,803 11 payments
  11. Other $8,275 40 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $187,597 55 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $72,379 20 payments
  3. Travel and Lodging $32,940 91 payments
  4. Education $16,448 9 payments
  5. Food and Beverage $14,601 165 payments
  6. Honoraria $400 1 payment
Products named General payments · program years 2019–2025
  1. CLARIFIX CRYOTHERAPY DEVICE $52,173 16 payments
  2. DUPIXENT $44,212 9 payments
  3. VIVAER STYLUS $39,355 35 payments
  4. XPRESS ENT DILATION SYSTEM $32,437 24 payments
  5. SCOPIS ENT $30,224 8 payments
  6. NUCALA $30,039 22 payments
  7. TGS GUIDEWIRE $18,571 5 payments
  8. SHAVER SYSTEM $18,071 4 payments
  9. FUSION $17,963 11 payments
  10. Celon System $17,156 26 payments
  11. Other $153,885 270 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

51

Median for Otolaryngology: 297

Drug cost

$1,090

Median for Otolaryngology: $6,314

Branded share of claims

0%

Median for Otolaryngology: 10.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ipratropium Bromide Generic 22 $763
Fluticasone Propionate Generic 29 $327

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 9,296 Part D prescribers listed as Otolaryngology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 40 billing codes

Paid by Medicare

$98,499

Medicare's payments for the services billed

Medicare patients

106

Average age 72

Services billed

500

60 women, 46 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 67%
Arthritis 64%
Diabetes 33%
Depression 29%
Ischemic heart disease 27%
Osteoporosis 27%
COPD 25%
Chronic kidney disease 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
NUCALA
  • GlaxoSmithKline, LLC. $134
$134 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

341 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record